More than 400 of the pharmaceutical industry's most senior global executives have signed a joint statement condemning the decision of a federal judge in the US state of Texas to overturn the FDA's approval of mifepristone. …
Industry leaders unite in response to US court's ruling that overturns FDA approval
April 12, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Priceline Pharmacy broadens women’s health support with new parenting program
September 2, 2026 - -
The non-disclosure agreement is just about creating a zone of controlled silence
September 2, 2026 - -
Roche maps a new chapter with move to new Sydney CBD location
September 2, 2026 - - Latest News -
CSL agrees to price certainty and a bigger US manufacturing footprint
September 2, 2026 - - Latest News -
New Zealand to fund flu vaccines for all children under five from 2027
September 1, 2026 - - Latest News -
GSK therapy becomes first biologic subsidised for Australians with uncontrolled COPD
September 1, 2026 - -
Those who ask questions and critique the process are treated as people who question and critique the process
September 1, 2026 - - Latest News